Sat.Aug 28, 2021 - Fri.Sep 03, 2021

article thumbnail

Italian ‘chatbot’ predicted COVID-19 spikes, says study

pharmaphorum

An online tool used by people in Italy to manage their potential exposure to COVID-19 using a simple chat interface has shown that it can spot emerging trends days ahead of the national surveillance system. The decision support system (DSS) – developed by Italian digital health startup Paginemediche – provided a way for people to assess and interpret their symptoms and provide guidance on what to do next, such as self-isolate or seek out a test.

Hospitals 144
article thumbnail

Ivermectin Demand Surges Though It Doesn’t Work for Covid-19

NY Times

Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug meant for horses.

122
122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Revive Therapeutics reports progress with Phase III COVID-19 trial

Outsourcing Pharma

A leader from the rare and infectious disease treatment specialist talks about ongoing research into a potential treatment for mild-to-moderate COVID-19.

131
131
article thumbnail

Codivir Shows Promising Effect Against COVID-19

Pharma Mirror

TEL AVIV, ISRAEL / DE BILT, NETHERLANDS – Codivir, a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, was originally discovered at the Hebrew University in Israel. Code Pharma discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the novel Coronavirus causing COVID-19. In-vitro studies conducted at the British virology research laboratory Virology Research Services in London then demonstrated a potent antiviral activity against SARS-CoV-2 and

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Real-world study suggest AI may improve atrial fibrillation screening

pharmaphorum

An artificial intelligence algorithm already shown to be able to detect atrial fibrillation (AF) in clinical testing has also shown its worth in a real-world setting, according to its developers. The AI – developed by the Bristol Myers Squibb-Pfizer Alliance on cardiovascular disease – was developed using machine learning from a UK dataset of almost 3 million patients and previously found to be more effective than existing testing at identifying patients at risk of AF based on retrospective stud

128
128
article thumbnail

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

NY Times

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

118
118

More Trending

article thumbnail

NICE, Cochrane to collaborate on delivery of ‘living’ recommendations

Pharma Times

Agreement will allow NICE to make ‘efficient and effective’ updates to recommendations in its guideline portfolio

95
article thumbnail

Funding round swells digital health firm Whoop’s value to $3.6bn

pharmaphorum

Fitness wearable company Whoop has raised another $200 million in funding that will help fund its expansion into international markets – and take on deep-pocketed rivals like Amazon, Apple and Google. The sixth-round financing was led by SoftBank’s Vision Fund 2, taking the total raised by the company to date to around $400 million, and catapults Whoop’s valuation to a massive $3.6 billion.

135
135
article thumbnail

Joe Rogan, A Podcasting Giant Who Has Been Dismissive of Vaccination, Has Covid

NY Times

“I got fevers, sweats, and I knew what was going on,” he said in a video on Instagram on Wednesday, after returning from a series of shows in Florida.

Vaccines 105
article thumbnail

UK consortium lands grant to construct digital supply chain

Outsourcing Pharma

FarmaTrust is helping assemble a collective of public and private firms working on solutions for smart manufacturing and creating medicines of the future.

105
105
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

GSK, SK to compare COVID-19 vaccine candidate to AZ’s jab

Pharma Times

Phase III trial will use AZ’s COVID-19 vaccine as an active comparator

Vaccines 112
article thumbnail

Purdue bankruptcy court hands immunity to Sackler family

pharmaphorum

A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further civil lawsuits accusing them of contributing to opioid epidemic – to the consternation of campaigners. The agreement will dissolve the OxyContin (oxycodone) manufacturer – which Judge Robert Drain said was a “bitter result” – will see around $4.5 billion being paid out by the Sackler family to projects that support victims of the o

article thumbnail

The Cocaine Was Laced With Fentanyl. Now 6 Are Dead From Overdoses.

NY Times

The deaths over three days in Suffolk County reflect a dangerous shift in the street-drug marketplace, according to police and prosecutors.

99
article thumbnail

Curebase to partner on VR-based chronic pain clinical trials

Outsourcing Pharma

The decentralized trial tech firm will work with Applied VR on five studies testing the viability of virtual-reality therapy in treating pain patients.

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Roche withdraws US approval for Tecentriq in mTNBC

Pharma Times

Metastatic triple-negative breast cancer treatment failed to meet PFS primary endpoint

104
104
article thumbnail

NICE backs NHS use of Novartis’ cholesterol drug Leqvio

pharmaphorum

Novartis’ cholesterol-lowering drug Leqvio will be made available on the NHS in England and Wales, and could help to prevent up to 30,000 deaths, according to NICE. The PCSK9-targeting oligonucleotide – which is already available in Scotland – requires dosing just twice a year and has been approved by the health technology assessment (HTA) agency for use in people with atherosclerotic cardiovascular disease (ASCVD) who can’t reach target cholesterol levels with oral statins alone.

98
article thumbnail

The Cocaine Was Laced With Fentanyl. Now Six Are Dead From Overdoses.

NY Times

The deaths over three days in Suffolk County reflect a dangerous shift in the street-drug marketplace, according to police and prosecutors.

95
article thumbnail

A Video History of Pharmacies and Prescription Prices: From Soda Fountains to GoodRx

Drug Channels

Charlotte Morabito at CNBC has put together “Why Pharmacies Overcharge,” an entertaining and provocative video on the pharmacy industry and its generic prescription pricing. It’s definitely worth your time. I especially enjoyed the cool visualizations of Drug Channels Institute’s industry data. Links below. The video covers the history of pharmacy, from the “Soda Fountain Era” to “Lick, Stick, and Pour” to the rise of PBMs and GoodRx. .

72
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

NICE recommends Novartis’ Cosentyx for children with severe psoriasis

Pharma Times

The monoclonal antibody is designed to block IL-17A, a molecule involved in the psoriasis inflammatory response

91
article thumbnail

How pharma can help the post-COVID recovery of European cancer care

pharmaphorum

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered. The publication, which has been supported by Accord Healthcare, also provides a series of recommendations for how the pharmaceutical industry can continue to support cancer care for the next 12 months and looks at what physicians want

100
100
article thumbnail

An Experimental H.I.V. Vaccine Fails in Africa

NY Times

Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.

article thumbnail

Johnson & Johnson pulls HIV vaccine trial in Africa; but pledges to continue with Phase 3 Mosaico study

Outsourcing Pharma

Johnson & Johnson has announced results from the primary analysis of its Imbokodo Phase 2b HIV vaccine clinical trial, with data showing the investigational HIV vaccine candidate did not provide sufficient protection against HIV infection. A Phase 3 trial with a different composition of the vaccine regimen and different populations, however, will continue.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

PMGroup Worldwide Ltd and The Datateam Media Group welcome Samedan Ltd

Pharma Times

Samedan joining PMGroup and PharmaTimes Media Ltd as part of The Datateam Media Group’s healthcare division

85
article thumbnail

FDA clears J&J’s twice-yearly Invega for schizophrenia

pharmaphorum

One of the biggest challenges to treating schizophrenia is non-compliance with treatment, but Johnson & Johnson’s pharma unit Janssen is trumpeting a new version of its Invega drug that could solve that problem. The FDA has just approved Janssen’s Invega Hafyera (paliperidone), a twice-yearly injectable formulation that extends the company’s big-selling brand and offers the fewest doses per year of any schizophrenia medicine.

97
article thumbnail

New patent for Bionpharma Inc drug NAPROXEN SODIUM

Drug Patent Watch

Annual Drug Patent Expirations for NAPROXEN+SODIUM Naproxen Sodium is a drug marketed by Bionpharma Inc, Catalent, Puracap Pharm Llc, Actavis Labs Fl Inc, Able, Amneal Pharms Ny, Aurobindo Pharma Ltd,…. The post New patent for Bionpharma Inc drug NAPROXEN SODIUM appeared first on DrugPatentWatch - Make Better Decisions.

63
article thumbnail

Survey: cancer patients missing out on much-needed genetic testing

Outsourcing Pharma

According to patient-matching specialist TrialJectory, 90% of cancer patients know the vitality of genetic testing but more than half are not being tested.

74
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Early use of Uptravi reduces risk of disease progression in PAH patients

Pharma Times

Phase III study finds risk reduced by 52% compared with control group

102
102
article thumbnail

AI breast cancer screening ‘not accurate enough to replace humans’

pharmaphorum

There is not enough evidence yet to allow artificial intelligence based breast cancer detection to be fully integrated into screening services, says a UK study. The analysis of a dozen studies of AI-powered image recognition software for breast cancer screening – published in the British Medical Journal – has found that the technology isn’t yet reliable enough to replace radiology specialists.

96
article thumbnail

The Intolerable Wait for a Kids’ Vaccine

NY Times

As children's hospital beds fill up, the F.D.A. shouldn't delay. .

article thumbnail

Study: Cancer patients frustrated with slow rate of treatment innovations

Outsourcing Pharma

Cota has released a survey revealing about two-thirds of cancer patients and their families are unsatisfied at the speed of cancer treatment development.

65
article thumbnail

Moderna submits its COVID-19 vaccine booster to the FDA

Pharma Times

Trial showed ‘robust antibody responses’ against Delta variant